More articles from Neurodegeneration: Preclinical to Clinical

You have access
Implementation of the Centiloid transformation for ¹⁸F-NAV4694: Comparison with PiB
Christopher Rowe, Gareth Jones, Svetlana Pejoska, Laura Margison, Rachel Mulligan, J. Gordon Chan, Colin Masters and Victor Villemagne

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 415;
You have access
In vivo quantitative PET/MR imaging of gene expression in Parkinson's Disease
Youngho Seo, Randall Hawkins, Chadwick Christine, Paul Larson and Krystof Bankiewicz

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 417;
You have access
Use of FDG-PET and MR imaging with cognitive testing in AD therapeutic development
Marcella Cline, Chloe Cross, Dalia Murra, Josh Yumul, Gregory Garwin, Satoshi Minoshima and Donna Cross

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 416;
You have access
Tracer kinetic analysis of (S)-[¹⁸F]THK5117 as a PET tracer for tau pathology
Mark Lubberink, My Jonasson, Anders Wall, Konstantinos Chiotis, Laure Saint-Aubert, Jonas Eriksson, Jens Sörensen, Nobuyuki Okamura, Gunnar Antoni and Agneta Nordberg

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 413;
You have access
Novel PET tracers for molecular imaging of Alzheimer’s disease
Sundaram Guruswami, paul kotzbauer, Nigel Cairns, john cirrito, jin-moo lee and Vijay Sharma

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 412;
You have access
Pharmacokinetic evaluation of the tau radiotracer [¹⁸F]T807
Dustin Wooten, Nicolas Guehl, Daniel Yokell, Timothy Shoup, Nevena Zubcevik, Ross Zafonte, Keith Johnson, Georges El Fakhri and Marc Normandin

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 414;
You have access
Glutamate-induced Hyperactivity of NMDA ion channel in Postmortem Alzheimer’s Disease Brains
Nehal Shah and Jogeshwar Mukherjee

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 411;

Main menu

User menu

Search

More articles from Neurodegeneration: Preclinical to Clinical